We are live on ! Find out more
KXA

KPCB XIII Associates Portfolio holdings

AUM $186M
1-Year Est. Return 11.23%
This Fund
S&P 500
This Quarter Est. Return
+24.49%
1 Year Est. Return
-11.23%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$543M
AUM Growth
+$56.9M
Cap. Flow
-$50M
Cap. Flow %
-9.2%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PGNY icon
Progyny
PGNY
+$50M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGNY icon
1
Progyny
PGNY
$2.46B
$437M 80.41%
7,406,115
-889,781
-11% -$50M
LUNG icon
2
Pulmonx
LUNG
$51.1M
$43.9M 8.08%
994,971
– –
EPZM
3
DELISTED
Epizyme, Inc
EPZM
$31.9M 5.87%
3,838,166
– –
TMDX icon
4
Transmedics
TMDX
$2.46B
$30.6M 5.64%
923,221
– –

Similar funds

BC
Bullfrog Capital Palo Alto, California $191M AUM 19.3% 1-Year Est. Return
CC
Claybrook Capital Wellesley, Massachusetts $175M AUM 10.74% 1-Year Est. Return
BAG
Briggs Advisory Group Lincoln, Rhode Island $175M AUM 16.29% 1-Year Est. Return
SWA
Sutton Wealth Advisors Tampa, Florida $203M AUM 20.54% 1-Year Est. Return
DLG
Daniel L. Goodwin $207M AUM 22.03% 1-Year Est. Return
NFAM
North Fourth Asset Management Englewood Cliffs, New Jersey $164M AUM 43.6% 1-Year Est. Return
RCGI
Ribbit Capital GP III Palo Alto, California $211M AUM 51.22% 1-Year Est. Return
TA
Trellis Advisors Ellensburg, Washington $219M AUM 17.82% 1-Year Est. Return

KPCB XIII Associates's Q2 2021 Portfolio in Review

As of Q2 2021, KPCB XIII Associates held 4 positions worth $543M, up 12% from $486M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

KPCB XIII Associates withdrew a net $50M in Q2 2021, reducing 1 holding. Its largest reduction was Progyny, cutting an estimated $50M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • KPCB XIII Associates's biggest Q2 2021 reduction was Progyny, cutting an estimated $50M.
  • KPCB XIII Associates's ten largest holdings make up 100% of its $543M portfolio in Q2 2021.
  • KPCB XIII Associates opened 0 new positions and closed 0 in Q2 2021.
  • KPCB XIII Associates's portfolio value rose 12% quarter-over-quarter to $543M.

Based on KPCB XIII Associates's 13F filing for Q2 2021, filed 28 Jul 2021.